Author

Caryn Cramer

Observed name: Cramer, Caryn

Institution: Aastrom Biosciences (United States)

Observed institution: Aastrom Biosciences (United States)

ORCID: 0009-0001-1167-396X

Observed ORCID: 0009-0001-1167-396X

OpenAlex ID: A5082587274

Consensus on Rehabilitation Guidelines among Orthopedic Surgeons in the United States following Use of Third-Generation Articular Cartilage Repair (MACI) for Treatment of Knee Cartilage Lesions

2020 · David C. Flanigan, Seth L. Sherman, et al. · Cartilage · 33

The Aastrom experience

2012 · Ronnda L Bartel, Caryn Cramer, et al. · Stem Cell Research & Therapy · 29

From Bench to Bedside: Review of Gene and Cell-Based Therapies and the Slow Advancement into Phase 3 Clinical Trials, with a Focus on Aastrom’s Ixmyelocel-T

2013 · Ronnda L. Bartel, Erin Booth, et al. · Stem Cell Reviews and Reports · 11

Establishing Consensus of Best Practice for CEA Use in Treatment of Severe Burns: A US Burn Provider Delphi Study

2024 · Paul Glat, Lisa Quirk, et al. · Journal of Burn Care & Research · 6

Application and Management of Cultured Epidermal Autografts on Posterior Burns—A 5-Year, Multicenter, Retrospective Review of Outcomes

2022 · Bounthavy Homsombath, Robert F Mullins, et al. · Journal of Burn Care & Research · 6

Report of outcomes in burn patients enrolled in the Cultured epidermal autograft prospective Registry

2023 · Shawn Fagan, Zaheed Hassan, et al. · Burns Open · 4

CEA graft take after combining with a modified MEEK procedure

2023 · Beretta Craft-Coffman, Bounthavy Homsombath, et al. · Burns Open · 4

Works count: 9

Citation count: 93

H-index: 5

I10-index: 3